These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 19745605)

  • 41. Gene expression profile of adipocyte differentiation and its regulation by peroxisome proliferator-activated receptor-gamma agonists.
    Gerhold DL; Liu F; Jiang G; Li Z; Xu J; Lu M; Sachs JR; Bagchi A; Fridman A; Holder DJ; Doebber TW; Berger J; Elbrecht A; Moller DE; Zhang BB
    Endocrinology; 2002 Jun; 143(6):2106-18. PubMed ID: 12021175
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A novel selective peroxisome proliferator-activator receptor-gamma modulator-SPPARgammaM5 improves insulin sensitivity with diminished adverse cardiovascular effects.
    Chang CH; McNamara LA; Wu MS; Muise ES; Tan Y; Wood HB; Meinke PT; Thompson JR; Doebber TW; Berger JP; McCann ME
    Eur J Pharmacol; 2008 Apr; 584(1):192-201. PubMed ID: 18346728
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Decreased brown adipocyte recruitment and thermogenic capacity in mice with impaired peroxisome proliferator-activated receptor (P465L PPARgamma) function.
    Gray SL; Dalla Nora E; Backlund EC; Manieri M; Virtue S; Noland RC; O'Rahilly S; Cortright RN; Cinti S; Cannon B; Vidal-Puig A
    Endocrinology; 2006 Dec; 147(12):5708-14. PubMed ID: 16980437
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Overexpression of PGC-1β improves insulin sensitivity and mitochondrial function in 3T3-L1 adipocytes.
    Gao CL; Liu GL; Liu S; Chen XH; Ji CB; Zhang CM; Xia ZK; Guo XR
    Mol Cell Biochem; 2011 Jul; 353(1-2):215-23. PubMed ID: 21499715
    [TBL] [Abstract][Full Text] [Related]  

  • 45. BNIP3 is essential for mitochondrial bioenergetics during adipocyte remodelling in mice.
    Choi JW; Jo A; Kim M; Park HS; Chung SS; Kang S; Park KS
    Diabetologia; 2016 Mar; 59(3):571-81. PubMed ID: 26693709
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anti-Inflammatory Effects of Rosiglitazone in Obesity-Impaired Wound Healing Depend on Adipocyte Differentiation.
    Siebert A; Goren I; Pfeilschifter J; Frank S
    PLoS One; 2016; 11(12):e0168562. PubMed ID: 27992530
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of DSP-8658, a novel selective peroxisome proliferator-activated receptors a/γ modulator, on adipogenesis and glucose metabolism in diabetic obese mice.
    Goto T; Nakayama R; Yamanaka M; Takata M; Takazawa T; Watanabe K; Maruta K; Nagata R; Nagamine J; Tsuchida A; Kato H
    Exp Clin Endocrinol Diabetes; 2015 Sep; 123(8):492-9. PubMed ID: 26011171
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dual peroxisome-proliferator-activated-receptor-α/γ activation inhibits SIRT1-PGC1α axis and causes cardiac dysfunction.
    Kalliora C; Kyriazis ID; Oka SI; Lieu MJ; Yue Y; Area-Gomez E; Pol CJ; Tian Y; Mizushima W; Chin A; Scerbo D; Schulze PC; Civelek M; Sadoshima J; Madesh M; Goldberg IJ; Drosatos K
    JCI Insight; 2019 Aug; 5(17):. PubMed ID: 31393858
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Peroxisome proliferator activated receptor-γ agonists protect oligodendrocyte progenitors against tumor necrosis factor-alpha-induced damage: Effects on mitochondrial functions and differentiation.
    De Nuccio C; Bernardo A; Cruciani C; De Simone R; Visentin S; Minghetti L
    Exp Neurol; 2015 Sep; 271():506-14. PubMed ID: 26210873
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Design, synthesis, and biological evaluation of a series of alkoxy-3-indolylacetic acids as peroxisome proliferator-activated receptor γ/δ agonists.
    Gim HJ; Li H; Jeong JH; Lee SJ; Sung MK; Song MY; Park BH; Oh SJ; Ryu JH; Jeon R
    Bioorg Med Chem; 2015 Jul; 23(13):3322-36. PubMed ID: 25982078
    [TBL] [Abstract][Full Text] [Related]  

  • 51. EID1-induces brown-like adipocyte traits in white 3T3-L1 pre-adipocytes.
    Lizcano F; Vargas D
    Biochem Biophys Res Commun; 2010 Jul; 398(2):160-5. PubMed ID: 20541531
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differential effects of YM440 a hypoglycemic agent on binding to a peroxisome proliferator-activated receptor gamma and its transactivation.
    Kurosaki E; Nakano R; Shimaya A; Yoshida S; Ida M; Suzuki T; Shibasaki M; Shikama H
    Biochem Pharmacol; 2003 Mar; 65(5):795-805. PubMed ID: 12628477
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transcriptional synergy and the regulation of Ucp1 during brown adipocyte induction in white fat depots.
    Xue B; Coulter A; Rim JS; Koza RA; Kozak LP
    Mol Cell Biol; 2005 Sep; 25(18):8311-22. PubMed ID: 16135818
    [TBL] [Abstract][Full Text] [Related]  

  • 54. FABP3 and brown adipocyte-characteristic mitochondrial fatty acid oxidation enzymes are induced in beige cells in a different pathway from UCP1.
    Nakamura Y; Sato T; Shiimura Y; Miura Y; Kojima M
    Biochem Biophys Res Commun; 2013 Nov; 441(1):42-6. PubMed ID: 24129192
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hematopoietic stem cell origin of adipocytes.
    Sera Y; LaRue AC; Moussa O; Mehrotra M; Duncan JD; Williams CR; Nishimoto E; Schulte BA; Watson PM; Watson DK; Ogawa M
    Exp Hematol; 2009 Sep; 37(9):1108-20, 1120.e1-4. PubMed ID: 19576951
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of peroxisome proliferator-activated receptor-alpha ligands in the interaction between adipocytes and macrophages in obese adipose tissue.
    Toyoda T; Kamei Y; Kato H; Sugita S; Takeya M; Suganami T; Ogawa Y
    Obesity (Silver Spring); 2008 Jun; 16(6):1199-207. PubMed ID: 18356826
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mitochondrial remodeling in adipose tissue associated with obesity and treatment with rosiglitazone.
    Wilson-Fritch L; Nicoloro S; Chouinard M; Lazar MA; Chui PC; Leszyk J; Straubhaar J; Czech MP; Corvera S
    J Clin Invest; 2004 Nov; 114(9):1281-9. PubMed ID: 15520860
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Depot-specific regulation of perilipin by rosiglitazone in a diabetic animal model.
    Kim HJ; Jung TW; Kang ES; Kim DJ; Ahn CW; Lee KW; Lee HC; Cha BS
    Metabolism; 2007 May; 56(5):676-85. PubMed ID: 17445544
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fenofibrate prevents Rosiglitazone-induced body weight gain in ob/ob mice.
    Carmona MC; Louche K; Nibbelink M; Prunet B; Bross A; Desbazeille M; Dacquet C; Renard P; Casteilla L; Pénicaud L
    Int J Obes (Lond); 2005 Jul; 29(7):864-71. PubMed ID: 15917863
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increased adipose expression of the uncoupling protein-3 gene by thiazolidinediones in Wistar fatty rats and in cultured adipocytes.
    Matsuda J; Hosoda K; Itoh H; Son C; Doi K; Hanaoka I; Inoue G; Nishimura H; Yoshimasa Y; Yamori Y; Odaka H; Nakao K
    Diabetes; 1998 Nov; 47(11):1809-14. PubMed ID: 9792555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.